Transport of methotrexate into LNCaP human prostate cancer cells

BioFactors

Volumn 16, Issue 1-2, 2002, Pages 19-27

  Horne, Donald W ^a   Reed, Kathleen A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LNCaP cells; Methotrexate; Prostate; Prostate cancer cells; Transport

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANION; FOLIC ACID; FOLINIC ACID; METHOTREXATE; ORGANIC COMPOUND; PHOSPHATE; SULFATE;

ANION EXCHANGE; ARTICLE; CANCER CELL CULTURE; CELL ENERGY; CELL MEMBRANE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MALE; PH; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURAL HOMOLOGY; TRANSPORT KINETICS;

EID: 0036948905     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520160103     Document Type: Article

References (26)

1. R.L. Blakley, The Biochemistry of Folic Acid and Related Pteridines, North-Holland, Amsterdam & London, 1969.
2. S.W. Choi and J.B. Mason, Folate and carcinogenesis: An integrated scheme, J. Nutr. 130 (2000), 129-132.
3. J. Selhub, Homocysteine metabolism, Ann. Rev. Nutr. 19 (1999), 217-246.
4. K. Pietrzik and A. Brönstrup, Folate in preventive medicine: A new role in cardiovascular disease, neural tube defects and cancer, Ann. Nutr. Metab. 41 (1997), 331-343.
5. J.T. Pinto, B.P. Suffoletto, T.M. Berzin, C.H. Qiao, S. Lin, W.P. Tong, F. May, B. Mukherjee and W.D.W. Heston, Prostate specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells, Clin. Cancer Res. 2 (1996), 1445-1451.
6. R.G. Lapidus, C.W. Tiffany, J.T. Isaacs and B.S. Slusher, Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells, Prostate 45 (2000), 350-354.
7. C.H. Halsted, E.H. Ling, R. Luthi-Carter, J.A. Villanueva, J.M. Gardner and J.T. Coyle, Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum - Molecular characterization and relation to glutamate carboxypeptidase II, J. Biol. Chem. 273 (1998), 20417-20424.
8. F.M. Sirotnak and B. Tolner, Carrier-mediated membrane transport of folates in mammalian cells, Ann. Rev. Nutr. 19 (1999), 91-122.
9. E.E. Sierra and I.D. Goldman, Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates, Semin. Oncol. 26 (1999), 11-23.
10. D.W. Horne and K.A. Reed, Transport of methotrexate into PC-3 human prostate cancer cells, Arch. Biochem. Biophys. 394 (2001), 39-44.
11. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976), 248-254.
12. W.L. Gabler, Fluxes and accumulation of tetracyclines by human blood cells, Res. Commun. Chem Pathol. Pharmacol. 72 (2000), 39-51.
13. E.E. Sierra, K.E. Brigle, M.J. Spinella and I.D. Goldman, pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells - Further evidence for a third route mediated at low pH, Biochem. Pharmacol. 53 (1997), 223-231.
14. + and pH dependence of 5-methyltetrahydrofolic acid and methotrexate transport in freshly isolated hepatocytes, Biochim. Biophys. Acta 1023 (1990), 47-55.
15. H.M. Said, F.K. Ghishan and R. Redha, Folate transport by human intestinal brush-border membrane vesicles, Am. J. Physiol. 252 (1987), G229-G236.
16. C.H. Schron, C. Washington, Jr. and B.L. Blitzer, The transmembrane pH gradient drives uphill folate transport in rabbit jejunum, J. Clin. Invest. 76 (1985), 2030-2033.
17. C.K. Kumar, T.T. Nguyen, F.B. Gonzales and H.M. Said, Comparison of intestinal folate carrier clone expressed in IEC-6 cells and in Xenopus oocytes, Am. J. Physiol. Cell Physiol. 274 (1998), C289-C294.
18. A. Rajgopal, E.E. Sierra, R. Zhao and I.D. Goldman, Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities, Am. J. Physiol. Cell Physiol. 281 (2001), C1579-C1586.
19. I.G. Sharina, R. Zhao, Y. Wang, S. Babani and I.D. Goldman, Mutational Analysis of the Functional Role of Conserved Arginine and Lysine Residues in Transmembrane Domains of the Murine Reduced Folate Carrier, Mol. Pharmacol. 59 (2001), 1022-1028.
20. D.W. Horne, K.A. Reed, J. Hoefs and H.M. Said, 5-Methyltetrahydrofolate transport in basolateral membrane vesicles from human liver, Am. J. Clin. Nutr. 58 (1993), 80-84.
21. I.D. Goldman, The characteristics of the membrane transport of amethopterin and the naturally occurring folates, Ann. N. Y. Acad. Sci. 186 (1971), 400-422.
22. G.B. Henderson and E.M. Zevely, Transport of methotrexate in L1210 cells: effects of ions on the rate and extent of uptake, Arch. Biochem. Biophys. 200 (1980), 149-155.
23. G.B. Henderson and E.M. Zevely, Structural requirements for anion substrates of the methotrexate transport system in L1210 cells, Arch. Biochem. Biophys. 221 (1983), 438-446.
24. C.-H. Yang, F.M. Sirotnak and M. Dembo, Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier, J. Membr. Biol. 79 (1984), 285-292.
25. D.W. Horne and K.A. Reed, Transport of methotrexate in basolateral membrane vesicles from rat liver, Arch. Biochem. Biophys. 298 (1992), 121-128.
26. D.W. Horne, K.A. Reed and H.M. Said, Transport of 5-methyltetrahydrofolic acid in basolateral membrane vesicles of rat liver, Am. J. Physiol. 262 (1992), G150-G158.